Medical Devices Series A Investors & VC Firms
1128 firms in this list, with a median first check of $500K. 245 of them lead rounds. Generated from verified public data and updated continuously.
Panacea Venture
SingaporeSeed–Late Stage
22 people
Angel Bridge Co.,Ltd.
TokyoSeed–Series B$70K – $33M
9 people
UKSE
SheffieldSeries A–Late Stage
34 people
J2 Ventures
BostonSeed–Series A
20 people
Allos Ventures
CincinnatiSeed–Series A$1M – $6M
6 people
Windham Capital Partners
New YorkSeries A–Growth$1M – $5M
17 people
TechVision Fonds
AachenPre-Seed–Series A$540K – $2.2M
19 people
Mitsui Global Investment
Menlo ParkPre-Seed–Late Stage$500K – $10M
12 people
VenturEast
BangaloreSeed–Series A
14 people
Lilly Asia Ventures
Hong KongPre-Seed–Series C
3 people
Adjuvant Capital
New YorkSeries A–Series B$10M – $25M
19 people
BioGenerator Ventures
St. LouisPre-Seed–Series A$50K – $250K
20 people
Btomorrow Ventures
LondonSeed–Series C
17 people
Myelin VC
MontevideoSeed–Series A$250K – $1M
8 people
AG Capital Co. Ltd.
TokyoSeed–Growth
1 person
Pivotal Life Sciences
San FranciscoPre-Seed–Late Stage
14 people
Takeda Ventures
CambridgePre-Seed–Series A$1M – $5M
20 people
DEEPCORE Inc.
TokyoSeed–Series A
28 people
Xeraya Capital
Kuala LumpurSeed–Growth
22 people
Avestria Ventures
San FranciscoPre-Seed–Series A
18 people
VI Partners
AltendorfSeed–Series A$2.2M – $4.5M
16 people
ZEISS Ventures
OberkochenPre-Seed–Series A$550K – $5.5M
22 people
Booster Innovation Fund
WellingtonSeed–Series A
15 people
LAV
Hong KongSeed–Series C$5M – $15M
3 people
Related lists
Series A Investors & VC Firms (7326)Series A Investors & VC Firms in North America (4220)Series A Investors & VC Firms in United States (3839)AI & Machine Learning Series A Investors & VC Firms (2601)SaaS Series A Investors & VC Firms (2591)Series A Investors & VC Firms in Europe (2384)Fintech Series A Investors & VC Firms (2350)Healthtech Series A Investors & VC Firms (2310)Enterprise Software Series A Investors & VC Firms (2265)Series A Investors & VC Firms in Global (2211)
Data sourced from public filings and firms' own websites — see our methodology.





























































































